The Problem with Medical Approach to Alzheimer's

The podcast discusses the significant problems with the medical approach to Alzheimer's disease in the United States. It highlights the high costs of treating patients and the lack of effective support for caregivers. The approval of a new Alzheimer's drug by the FDA is criticized, as the drug's effectiveness is uncertain, yet it comes at a high cost of $56,000 per patient per year. The article argues that the focus should be on providing practical functional supports and low-cost effective treatments, rather than spending on expensive drugs with questionable benefits.